Search
Selected Filter
Displaying 1–10 of 234 research results
-
Investigators Report Partial Vision Restoration for One Patient in Optogenetic Therapy Trial
The gene-agnostic approach is designed to restore some vision to people with advanced vision loss
-
Biogen’s Phase 2/3 Clinical Trial for XLRP Gene Therapy Doesn’t Meet Primary Endpoint
More details from the clinical trial will be reported at a later date
-
AGTC Continues to Report Encouraging Data from its Phase 1/2 XLRP Gene Therapy Clinical Trial
The company is planning the launch of a Phase 2/3 trial for its XLRP gene therapy
-
Precise and Sensitive Outcome Measures are Essential for Getting Vision Treatments through Clinical Trials
-
ARVO 2021 Highlight: CRISPR/Cas9 Therapy Emerging for Dominant RP Caused by RP1 Mutations
Gene-editing approaches are often better suited for autosomal dominant retinal diseases than gene replacement therapies
-
ARVO 2021 Highlight: Update on Clinical Trial of jCyte’s Cellular Therapy for RP
Cellular treatment provided significant improvements in visual acuity for subpopulation of patients with better vision
-
SparingVision to Acquire Therapy for Resurrecting Dormant Cones for Vision Restoration
The gene-agnostic approach shows promise for people with late-stage RP and related diseases.
-
Age-Related Macular Degeneration Research Advances
Recent developments in research on age-related macular degeneration.
-
Retinitis Pigmentosa Research Advances
Recent developments in research on retinitis pigmintosa.
-
Usher Syndrome Research Advances
Recent developments in research on Usher Syndrome.
.png)
